|
|
Article: Nobex Raises Two Year's Cash Through $35M Private Placement.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Nobex Corp. raised $35 million in equity financing through a private placement of Series F preferred stock, just months after it secured a development deal with GlaxoSmithKline plc.
"This funding will enable us to progress several products in clinical and preclinical studies," Nobex President and CEO Christopher Price told BioWorld Today. "We aimed at raising an amount of money that would give us about two years of cash."
Price added that it gives Nobex a secure position even if anticipated money from other deals "does not come through as planned." Including this round, Nobex has raised $78 million to date, he said.
The ...
Related newspaper, magazine, and journal articles:
|